Brind.

The FDA is overseeing a multicenter IDE study involving a new reverse-geometry design for a reverse hip replacement system at Tampa General Hospital.

1 report, 1 independent Updated Jul 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA Tampa General Hospital

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Tampa General Hospital
hospital in Florida, United States

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 6orthospinenews.com